Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Fibrinolytic Dysregulation Contributes to the Hypercoagulable State in Pulmonary Embolism Patients

Fakiha Siddiqui, Amir Darki, Emily Bontekoe, Yevgeniy Brailovsky, Omer Iqbal, Debra Hoppensteadt, Bulent Kantarcioglu, Alfonso J Tafur, Jawed Fareed

Blood (2021) 138 (Supplement 1): 3177.

https://doi.org/10.1182/blood-2021-153380

Published: 2021

Journal Articles

USP Standardized Mixtures of Bovine, Ovine and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single Sourced Heparins and May be Interchangeable,

Guy Olson, Walter Jeske, Omer Iqbal, Ambar Farooqui, Fakiha Siddiqui, Debra Hoppensteadt, Ahmed Kouta, Jawed Fareed, Eduardo Ramacciotti

Blood (2021) 138 (Supplement 1): 1067.

https://doi.org/10.1182/blood-2021-147995

Published: 2021

Journal Articles

Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine, and Bovine Heparins

Nausheen Baig, Ahmed Kouta, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Omer Iqbal, MD, Fakiha Siddiqui, Mamdouh Bakhos, MD, Jawed Fareed, PhD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-142861

Published: 2020

Journal Articles

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Ahmed Kouta, Walter Jeske, PhD, Rick Duff, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 165.

https://doi.org/10.1182/blood-2019-131943

Published: 2019

Journal Articles

Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma

Debra Hoppensteadt, PhD, Emily Bontekoe, Fakiha Siddiqui, Ambar Farooqui, Omer Iqbal, MD, Walter Jeske, PhD, Jeanine Walenga, PhD, Alfonso J Tafur, MD MS, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 3374.

https://doi.org/10.1182/blood-2019-131221

Published: 2019

Journal Articles

Bovine Heparin Demonstrates the Same Interaction with HIT Antibodies As Porcine Heparin

Jeanine Walenga, PhD, Walter Jeske, PhD, Sabrina Bertini, Giulia Risi, Michelle Sung, BS, Ambar Farooqui, Cassie Bacher, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Bruce Lewis, Mamdouh Bakhos, MD

Blood (2019) 134 (Supplement_1): 2351.

https://doi.org/10.1182/blood-2019-127304

Published: 2019

Journal Articles

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

Ambar Farooqui, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Cassie Bacher, Jeanine Walenga, PhD, Ahmed Kouta, Walter Jeske, PhD, Bruce Lewis, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 2446.

https://doi.org/10.1182/blood-2019-131825

Published: 2019

Journal Articles

Potency Equated Porcine and Bovine Mucosal Heparin Are Bioequivalent in Terms of Biochemical and Pharmacological Effects

Nausheen Baig, Ahmed Kouta, Fakiha Siddiqui, Ambar Farooqui, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Cassie Bacher, Sharan Krishnappan, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 3665.

https://doi.org/10.1182/blood-2019-126075

Published: 2019

Journal Articles

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban By Andexanet Alfa As Measured By Whole Blood Thromboelastographic Analysis

Siddharth Mehrotra, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Alfonso J Tafur, MD MS, Bruce Lewis, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 1155.

https://doi.org/10.1182/blood-2019-131907

Published: 2019

Journal Articles

Symptom Duration Is Positively Correlated with Factor XIIIa Activity in Acute Pulmonary Embolism

Yevgeniy Brailovsky, DO, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Kevin Simpson, Nathan Mcclane, Jawed Fareed, PhD, Amir Darki, MD MSc

Blood (2018) 132 (Supplement 1): 5047.

https://doi.org/10.1182/blood-2018-99-119733

Published: 2018

Journal Articles

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

Fakiha Siddiqui, Siddharth Mehrotra, Vishnu Venkitasubramony, Rithik Raina, Lorenzo Storino Ramacciotti, Jack Bontekoe, BS, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Jawed Fareed, PhD

Blood (2018) 132 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2018-99-116993

Published: 2018

Journal Articles

Comparing a New Bovine Source Heparin to the Clinically Used Porcine Heparin for Platelet Function Effects and Heparin-Induced Thrombocytopenia Potential

Michelle Sung, BS, Jeanine Walenga, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Mamdouh Bakhos, MD

Blood (2018) 132 (Supplement 1): 2540.

https://doi.org/10.1182/blood-2018-99-118781

Published: 2018

Journal Articles

Bovine Heparin Compared to Porcine Heparin to Demonstrate Bioequivalence

Marco Khiella, Walter Jeske, PhD, Jeanine Walenga, PhD, Omer Iqbal, MD, Rajan Laddu, Fakiha Siddiqui, Mamdouh Bakhos, MD

Blood (2018) 132 (Supplement 1): 1253.

https://doi.org/10.1182/blood-2018-99-118809

Published: 2018

Journal Articles

Differential Modulation of Plasminogen Activator Mediated Thrombolysis By Recombinant Thrombomodulin and Activated Protein C

Jawed Fareed, PhD, Zafar Siddiqui, Sanchayana Raghuvir, Sid Mehrota, Omer Iqbal, Walter Jeske, Debra Hoppensteadt, PhD, Kosuke Tanaka, Kazuhisa Tsuruta

Blood (2017) 130 (Supplement 1): 4865.

https://doi.org/10.1182/blood.V130.Suppl_1.4865.4865

Published: 2017

Journal Articles

Comparative Studies on a Branded Recombinant Factor VIIa and Its Generic Version to Demonstrate Bioequivalence

Nasir Sadeghi, Zafar Siddiqui, Omer Iqbal, Schuharazad Abro, Debra Hoppensteadt, PhD, Michael Mosier, Jeanine Walenga, Jawed Fareed, PhD, Ahmed Kouta

Blood (2017) 130 (Supplement 1): 4868.

https://doi.org/10.1182/blood.V130.Suppl_1.4868.4868

Published: 2017

Journal Articles

Biochemical and Pharmacological Differentiation of APC and Recombinant Thrombomodulin with Reference to the Effect on the Hemostatic and Fibrinolytic Processes

Jawed Fareed, PhD, Debra Hoppensteadt, PhD, Walter Jeske, Omer Iqbal, Schuharazad Abro, Destini Clarizio, Sanchayana Raghuvir, Rachael Wasmund, Kosuke Tanaka, Kazuhisa Tsuruta

Blood (2017) 130 (Supplement 1): 4871.

https://doi.org/10.1182/blood.V130.Suppl_1.4871.4871

Published: 2017

Journal Articles

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Walter Jeske, Mary Lewis, Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, Jawed Fareed, PhD, Sid Mehrota

Blood (2017) 130 (Supplement 1): 4905.

https://doi.org/10.1182/blood.V130.Suppl_1.4905.4905

Published: 2017

Journal Articles

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, MD, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD, Mary Lewis

Blood (2016) 128 (22): 2608.

https://doi.org/10.1182/blood.V128.22.2608.2608

Published: 2016

Journal Articles

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Zafar Siddiqui, Parul Aggarwal, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Schuharazad Abro, MD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD

Blood (2016) 128 (22): 4974.

https://doi.org/10.1182/blood.V128.22.4974.4974

Published: 2016

Journal Articles

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Zafar Siddiqui, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Rohan Rege, Schuharazad Abro, MD, Jawed Fareed, PhD

Blood (2016) 128 (22): 2622.

https://doi.org/10.1182/blood.V128.22.2622.2622

Published: 2016

NARROW

Fibrinolytic Dysregulation Contributes to the Hypercoagulable State in Pulmonary Embolism Patients

USP Standardized Mixtures of Bovine, Ovine and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single Sourced Heparins and May be Interchangeable,

Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine, and Bovine Heparins

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma

Bovine Heparin Demonstrates the Same Interaction with HIT Antibodies As Porcine Heparin

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

Potency Equated Porcine and Bovine Mucosal Heparin Are Bioequivalent in Terms of Biochemical and Pharmacological Effects

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban By Andexanet Alfa As Measured By Whole Blood Thromboelastographic Analysis

Symptom Duration Is Positively Correlated with Factor XIIIa Activity in Acute Pulmonary Embolism

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

Comparing a New Bovine Source Heparin to the Clinically Used Porcine Heparin for Platelet Function Effects and Heparin-Induced Thrombocytopenia Potential

Bovine Heparin Compared to Porcine Heparin to Demonstrate Bioequivalence

Differential Modulation of Plasminogen Activator Mediated Thrombolysis By Recombinant Thrombomodulin and Activated Protein C

Comparative Studies on a Branded Recombinant Factor VIIa and Its Generic Version to Demonstrate Bioequivalence

Biochemical and Pharmacological Differentiation of APC and Recombinant Thrombomodulin with Reference to the Effect on the Hemostatic and Fibrinolytic Processes

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only